# Bausch Health Reports Higher Quarterly Profit and Raises Revenue Outlook

The company reported $2.94 billion in consolidated quarterly revenue and authorized a $50 million share repurchase program.

By Will Langan | 24X7 News
Published: 2026-10-28T20:11:04.048Z
Updated: 2026-10-28T20:11:04.048Z
Section: Business
Format: News
Canonical: https://24x7news.us/articles/bausch-health-third-quarter-results-october-28-2026

Bausch Health reported October 28 that consolidated third-quarter revenue rose 10% from a year earlier to $2.94 billion, while net income attributable to the company increased to $436 million from $179 million.

Diluted earnings were $1.15 a share, compared with 48 cents in the third quarter of 2025. Consolidated operating income reached $983 million, up from $619 million, for the period ended September 30.

The company said its Salix business generated $831 million in quarterly revenue, a 16% increase. Bausch + Lomb contributed $1.375 billion, up 7%.

Bausch Health raised its outlook and now projects consolidated 2026 revenue of $10.975 billion to $11.175 billion. The forecast includes Bausch + Lomb and represents management's expectations for the full year.

The board also authorized a $50 million share repurchase program. The company said its primary purpose is to offset dilution associated with management equity awards expected to vest in 2027. Authorization does not mean all those purchases have occurred.

Sources
- Bausch Health quarterly release via PR Newswire, carried by StreetInsider: https://www.streetinsider.com/PRNewswire/BAUSCH%2BHEALTH%2BANNOUNCES%2BTHIRD%2BQUARTER%2B2026%2BRESULTS,%2BRAISES%2BGUIDANCE/27248956.html

## Sources
- Bausch Health / PR Newswire via StreetInsider: https://www.streetinsider.com/PRNewswire/BAUSCH%2BHEALTH%2BANNOUNCES%2BTHIRD%2BQUARTER%2B2026%2BRESULTS,%2BRAISES%2BGUIDANCE/27248956.html